Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Biliary Tract Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05705492
What this trial is testing

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmAdvanced Biliary Tract CarcinomaAdvanced Esophageal Carcinoma+7 more
OHSU Knight Cancer Institute 66
Testing effectiveness (Phase 2)Looking for participantsNCT07670273
What this trial is testing

Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib as First-Line Therapy for Advanced HER2-Positive/HER2-Low Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital 70
Testing effectiveness (Phase 2)Study completedNCT01943864
What this trial is testing

A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers

Who this might be right for
Cancer
GlaxoSmithKline 20
Early research (Phase 1)Ended earlyNCT01949870
What this trial is testing

Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study

Who this might be right for
Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
AstraZeneca 6
Testing effectiveness (Phase 2)Looking for participantsNCT07038343
What this trial is testing

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Who this might be right for
Solid Tumor CancerLocally AdvancedMetastatic Solid Tumors+5 more
Avenzo Therapeutics, Inc. 480
Testing effectiveness (Phase 2)Looking for participantsNCT06778031
What this trial is testing

A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 54
Large-scale testing (Phase 3)Study completedNCT00513539
What this trial is testing

Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
University College, London 92
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07129018
What this trial is testing

Trastuzumab Rezetecan Combined With Pertuzumab and Iparomlimab and Tuvonralimab for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)First-line Therapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 63
Early research (Phase 1)Ended earlyNCT02908451
What this trial is testing

AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer

Who this might be right for
Gastric CancerColorectal CancerPancreatic Cancer+1 more
AbGenomics B.V Taiwan Branch 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT03801083
What this trial is testing

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

Who this might be right for
Biliary Tract CancerCholangiocarcinomaBiliary Tract Neoplasms
Udai Kammula 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT04579380
What this trial is testing

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Who this might be right for
Uterine NeoplasmsUterine Cervical NeoplasmsBiliary Tract Neoplasms+3 more
Seagen, a wholly owned subsidiary of Pfizer 217
Early research (Phase 1)Study completedNCT04641871
What this trial is testing

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 78
Testing effectiveness (Phase 2)UnknownNCT05978609
What this trial is testing

Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer

Who this might be right for
Cholangiocarcinoma Non-resectable
West China Hospital 65
Early research (Phase 1)Study completedNCT02351765
What this trial is testing

ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers

Who this might be right for
Biliary Tract CancerGallbladder CancerCholangiocarcinoma+1 more
The Christie NHS Foundation Trust 21
Testing effectiveness (Phase 2)Study completedNCT00073905
What this trial is testing

Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+1 more
Swiss Cancer Institute 44
Testing effectiveness (Phase 2)UnknownNCT05620498
What this trial is testing

Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC.

Who this might be right for
Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Large-scale testing (Phase 3)Looking for participantsNCT07582315
What this trial is testing

A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01)

Who this might be right for
Biliary Tract Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 538
Testing effectiveness (Phase 2)Active Not RecruitingNCT06792435
What this trial is testing

XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.

Who this might be right for
Pancreatic Adenocarcinoma MetastaticLung Cancer (NSCLC)Ovarian Cancer+4 more
Astellas Pharma Global Development, Inc. 240
Testing effectiveness (Phase 2)Ended earlyNCT00478140
What this trial is testing

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderMalignant Neoplasm+4 more
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Looking for participantsNCT05523947
What this trial is testing

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

Who this might be right for
HER2-Positive Solid Tumor
Yuhan Corporation 147
Next Page